Hypoxia-inducible Factor Inhibitor

All categories
Name
Hypoxia-inducible Factor Inhibitor
Accession Number
DBCAT005837
Description

Not Available

Drugs
DrugDrug Description
BelzutifanAn inhibitor of hypoxia-inducible factor 2α used as an antineoplastic in the treatment of certain cancers associated with von Hippel-Lindau (VHL) disease.
Drugs & Drug Targets
DrugTargetType
BelzutifanEndothelial PAS domain-containing protein 1target
BelzutifanUDP-glucuronosyltransferase 2B17enzyme
BelzutifanCytochrome P450 2C19enzyme
BelzutifanCytochrome P450 3A4enzyme
BelzutifanATP-dependent translocase ABCB1transporter
BelzutifanSolute carrier organic anion transporter family member 1B1transporter
BelzutifanSolute carrier organic anion transporter family member 1B3transporter
BelzutifanMultidrug and toxin extrusion protein 2transporter